A critical role for complement C3d and the B cell coreceptor (CD19/CD21) complex in the initiation of inflammatory arthritis

Journal of Immunology

Volumn 175, Issue 8, 2005, Pages 5379-5389

  Del Nagro, Christopher J ^a,b   Kolla, Ravi V ^a,b   Rickert, Robert C ^a  

^a BURNHAM INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; B LYMPHOCYTE RECEPTOR; CD19 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C3D RECEPTOR; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 2; INTERLEUKIN 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN EXPRESSION; ARTHRITIS; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL PROLIFERATION; COMPLEMENT SYSTEM; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; INFLAMMATORY DISEASE; LYMPH NODE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 26844550259     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.175.8.5379     Document Type: Article

References (61)

1. van Crevel, R., T. H. M. Ottenhoff, and J. W. M. van der Meer. 2002. Innate immunity to Mycobacterium tuberculosis. Clin. Microbiol. Rev. 15: 294-309.
2. Schlesinger, L., C. Bellinger-Kawahara, N. Payne, and M. Horwitz. 1990. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3. J. Immunol. 144: 2771-2780.
3. Morgan, B. P., and C. L. Harris. 1999. Complement Regulatory Proteins. Academic Press, San Diego.
4. Nielsen, C. H., and R. G. Leslie. 2002. Complement's participation in acquired immunity. J. Leukocyte Biol. 72: 249-261.
5. Rickert, R. C. 2005. Regulation of B lymphocyte activation by complement C3 and the B cell coreceptor complex. Curr. Opin. Immunol. 17: 237-243.
6. Carter, R. H., and D. T. Fearon. 1992. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256: 105-107.
7. Dempsey, P. W., M. E. Allison, S. Akkaraju, C. C. Goodnow, and D. T. Fearon. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271: 348-350.
8. Sato, S., D. A. Steeber, and T. F. Tedder. 1995. The CD19 signal transduction molecule is a response regulator of B-lymphocyte differentiation. Proc. Natl. Acad. Sci. USA 92: 11558-11562.
9. Rickert, R. C., K. Rajewsky, and J. Roes. 1995. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352-355.
10. Fehr, T., R. C. Rickert, B. Odermatt, J. Roes, K. Rajewsky, H. Hengartner, and R. M. Zinkernagel. 1998. Antiviral protection and germinal center formation, but impaired B cell memory in the absence of CD19. J. Exp. Med. 188: 145-155.
11. Ahearn, J. M., M. B. Fischer, D. Croix, S. Goerg, M. Ma, J. Xia, X. Zhou, R. G. Howard, T. L. Rothstein, and M. C. Carroll. 1996. Disruption of the Cr2 locus results in a reduction in B-1a cells and in an impaired B cell response to T-dependent antigen. Immunity 4: 251-262.
12. Molina, H., V. M. Holers, B. Li, Y. Fung, S. Mariathasan, J. Goellner, J. Strauss-Schoenberger, R. W. Karr, and D. D. Chaplin. 1996. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc. Natl. Acad. Sci. USA 93: 3357-3361.
13. Fischer, M. B., M. Ma, S. Goerg, X. Zhou, J. Xia, O. Finco, S. Han, G. Kelsoe, R. G. Howard, T. L. Rothstein, et al. 1996. Regulation of the B cell response to T-dependent antigens by classical pathway complement. J. Immunol 157: 549-556.
14. Haas, K. M., M. Hasegawa, D. A. Steeber, J. C. Poe, M. D. Zabel, C. B. Bock, D. R. Karp, D. E. Briles, J. H. Weis, and T. F. Tedder. 2002. Complement receptors CD21/35 link innate and protective immunity during Streptococcus pneumoniae infection by regulating IgG3 antibody responses. Immunity 17: 713-723.
15. Martin, F., and J. F. Kearney. 2002. Marginal-zone B cells. Nat. Rev. Immunol. 2: 323-335.
16. Barrington, R. A., O. Pozdnyakova, M. R. Zafari, C. D. Benjamin, and M. C. Carroll. 2002. B lymphocyte memory: role of stromal cell complement and FcγRIIB receptors. J. Exp. Med. 196: 1189-1199.
17. Fang, Y., C. Xu, Y. X. Fu, V. M. Holers, and H. Molina. 1998. Expression of complement receptors 1 and 2 on follicular dendritic cells is necessary for the generation of a strong antigen-specific IgG. J. Immunol. 160: 5273-5279.
18. Gulati, P., D. Guc, C. Lemercier, D. Lappin, and K. Whaley. 1994. Expression of the components and regulatory proteins of the classical pathway of complement in normal and diseased synovium. Rheumatol. Int. 14: 13-19.
19. Morgan, B. P., R. H. Daniels, and B. D. Williams. 1988. Measurement of terminal complement complexes in rheumatoid arthritis. Clin. Exp. Immunol. 73: 473-478.
20. Garnero, P., and P. D. Delmas. 2004. Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers. Curr. Opin. Rheumatol. 16: 428-434.
21. Luross, J. A., and N. A. Williams. 2001. The genetic and immunopathological processes underlying collagen-induced arthritis. Immunology 103: 407-416.
22. Trentham, D. E., A. S. Townes, and A. H. Kang. 1977. Autoimmunity to type II collagen an experimental model of arthritis. J. Exp. Med. 146: 857-868.
23. Holmdahl, R., L. Jansson, D. Gullberg, K. Rubin, P. O. Forsberg, and L. Klareskog. 1985. Incidence of arthritis and autoreactivity of anti-collagen antibodies after immunization of DBA/1 mice with heterologous and autologous collagen II. Clin. Exp. Immunol. 62: 639-646.
24. Ranges, G. E., S. Sriram, and S. M. Cooper. 1985. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J. Exp. Med. 162: 1105-1110.
25. Svensson, L., J. Jirholt, R. Holmdahl, and L. Jansson. 1998. B cell-deficient mice do not develop type II collagen-induced arthritis (CIA). Clin. Exp. Immunol. 111: 521-526.
26. Wooley, P. H., H. S. Luthra, C. J. Kreo, J. M. Stuart, and C. S. David. 1984. Type II collagen-induced arthritis in mice. II. Passive transfer and suppression by intravenous injection of anti-type II collagen antibody or free native type II collagen. Arthritis Rheum. 27: 1010-1017.
27. Catchpole, B., N. A. Staines, and A. S. Hamblin. 2001. Antigen presentation of type II collagen in rats. Clin. Exp. Immunol. 125: 478-484.
28. Takemura, S., P. A. Klimiuk, A. Braun, J. J. Goronzy, and C. M. Weyand. 2001. T cell activation in rheumatoid synovium is B cell dependent. J. Immunol. 167: 4710-4718.
29. Terato, K., K. A. Hasty, R. A. Reife, M. A. Cremer, A. H. Kang, and J. M. Stuart. 1992. Induction of arthritis with monoclonal antibodies to collagen. J. Immunol. 148: 2103-2108.
30. Stuart, J. M., and F. J. Dixon. 1983. Serum transfer of collagen-induced arthritis in mice. J. Exp. Med. 158: 378-392.
31. Wipke, B. T., Z. Wang, W. Nagengast, D. E. Reichert, and P. M. Allen. 2004. Staging the initiation of autoantibody-induced arthritis: a critical role for immune complexes. J. Immunol. 172: 7694-7702.
32. Reife, R. A., N. Loutis, W. C. Watson, K. A. Hasty, and J. M. Stuart. 1991. SWR mice are resistant to collagen-induced arthritis but produce potentially arthritogenic antibodies. Arthritis Rheum. 34: 776-781.
33. Hietala, M. A., I. M. Jonsson, A. Tarkowski, S. Kleinau, and M. Pekna. 2002. Complement deficiency ameliorates collagen-induced arthritis in mice. J. Immunol. 169: 454-459.
34. Grant, E. P., D. Picarella, T. Burwell, T. Delaney, A. Croci, N. Avitahl, A. A. Humbles, J.-C. Gutierrez-Ramos, M. Briskin, C. Gerard, et al. 2002. Essential role for the C5a receptor in regulating the effector phase of synovial infiltration and joint destruction in experimental arthritis. J. Exp. Med. 196: 1461-1471.
35. Kleinau, S., P. Martinsson, and B. Heyman. 2000. Induction and suppression of collagen-induced arthritis is dependent on distinct Fcγ receptors. J. Exp. Med. 191: 1611-1616.
36. Kagari, T., D. Tanaka, H. Doi, and T. Shimozato. 2003. Essential role of Fcγ receptors in anti-type II collagen antibody-induced arthritis. J. Immunol. 170: 4318-4324.
37. Watson, W. C., and A. S. Townes. 1985. Genetic susceptibility to murine collagen II autoimmune arthritis: proposed relationship to the IgG2 autoantibody sub-class response, complement C5, major histocompatibility complex (MHC) and non-MHC loci. J. Exp. Med. 162: 1878-1891.
38. Haas, K. M., F. R. Toapanta, J. A. Oliver, J. C. Poe, J. H. Weis, D. R. Karp, J. F. Bower, T. M. Ross, and T. F. Tedder. 2004. Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. J. Immunol. 172: 5833-5837.
39. Ross, T. M., Y. Xu, R. A. Bright, and H. L. Robinson. 2000. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge. Nat. Immunol. 1: 127-131.
40. Schulte, S., C. Unger, J. A. Mo, O. Wendler, E. Bauer, S. Frischholz, K. von der Mark, J. R. Kalden, R. Holmdahl, and H. Burkhardt. 1998. Arthritis-related B cell epitopes in collagen II are conformation-dependent and sterically privileged in accessible sites of cartilage collagen fibrils. J. Biol. Chem. 273: 1551-1561.
41. Gerlag, D. M., L. Ransone, P. P. Tak, Z. Han, M. Palanki, M. S. Barbosa, D. Boyle, A. M. Manning, and G. S. Firestein. 2000. The effect of a T cell-specific NF-κB inhibitor on in vitro cytokine production and collagen-induced arthritis. J. Immunol. 165: 1652-1658.
42. Gardby, E., and N. Y. Lycke. 2000. CD19-deficient mice exhibit poor responsiveness to oral immunization despite evidence of unaltered total IgA levels, germinal centers and IgA-isotype switching in Peyer's patches. Eur. J. Immunol. 30: 1861-1871.
43. -/- mice is rescued by adjuvants without improvement in germinal center development. J. Immunol. 165: 3119-3127.
44. Doherty, M., N. Richards, J. Hornby, and R. Powell. 1988. Relation between synovial fluid C3 degradation products and local joint inflammation in rheumatoid arthritis, osteoarthritis, and crystal associated arthropathy. Ann. Rheum. Dis. 47: 190-197.
45. Negi, V. S., A. Aggarwal, R. Dayal, S. Naik, and R. Misra. 2000. Complement degradation product C3d in urine: marker of lupus nephritis. J. Rheumatol. 27: 380-383.
46. Courtenay, J. S., M. J. Dallman, A. D. Dayan, A. Martin, and B. Mosedale. 1980. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283: 666-668.
47. Banda, N. K., D. M. Kraus, M. Muggli, A. Bendele, V. M. Holers, and W. P. Arend. 2003. Prevention of collagen-induced arthritis in mice transgenic for the complement inhibitor complement receptor 1-related gene/protein. J. Immunol. 171: 2109-2115.
48. Hietala, M. A., K. S. Nandakumar, L. Persson, S. Fahlen, R. Holmdahl, and M. Pekna. 2004. Complement activation by both classical and alternative pathways is critical for the effector phase of arthritis. Eur. J. Immunol. 34: 1208-1216.
49. Croix, D. A., J. M. Ahearn, A. M. Rosengard, S. Han, G. Kelsoe, M. Ma, and M. C. Carroll. 1996. Antibody response to a T-dependent antigen requires B cell expression of complement receptors. J. Exp. Med. 183: 1857-1864.
50. Noorchashm, H., D. J. Moore, Y. K. Lieu, N. Noorchashm, A. Schlachterman, H. K. Song, C. F. Barker, and A. Naji. 1999. Contribution of the innate immune system to autoimmune diabetes: a role for the CR1/CR2 complement receptors. Cell. Immunol. 195: 75-79.
51. Walport, M. J. 2002. Complement and systemic lupus erythematosus. Arthritis Res. 4(Suppl. 3): S279-S293.
52. Chan, O. T., M. P. Madaio, and M. J. Shlomchik. 1999. The central and multiple roles of B cells in lupus pathogenesis. Immunol. Rev. 169: 107-121.
53. Da Costa, X. J., M. A. Brockman, E. Alicot, M. Ma, M. B. Fischer, X. Zhou, D. M. Knipe, and M. C. Carroll. 1999. Humoral response to herpes simplex virus is complement-dependent. Proc. Natl. Acad. Sci. USA 96: 12708-12712.
54. Kopf, M., B. Abel, A. Gallimore, M. Carroll, and M. F. Bachmann. 2002. Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection. Nat. Med. 8: 373-378.
55. Gustavsson, S., T. Kinoshita, and B. Heyman. 1995. Antibodies to murine complement receptor 1 and 2 can inhibit the antibody response in vivo without inhibiting T helper cell induction. J. Immunol. 154: 6524-6528.
56. Boackle, S. A., V. M. Holers, and D. R. Karp. 1997. CD21 augments antigen presentation in immune individuals. Eur. J. Immunol. 27: 122-129.
57. Barrault, D. V., and A. M. Knight. 2004. Distinct sequences in the cytoplasmic domain of complement receptor 2 are involved in antigen internalization and presentation. J. Immunol. 172: 3509-3517.
58. Hess, M. W., M. G. Schwendinger, E. L. Eskelinen, K. Pfaller, M. Pavelka, M. P. Dierich, and W. M. Prodinger. 2000. Tracing uptake of C3dg-conjugated antigen into B cells via complement receptor type 2 (CR2, CD21). Blood 95: 2617-2623.
59. Cherukuri, A., P. C. Cheng, and S. K. Pierce. 2001. The role of the CD19/CD21 complex in B cell processing and presentation of complement-tagged antigens. J. Immunol. 167: 163-172.
60. Thornton, B. P., V. Vetvicka, and G. D. Ross. 1994. Natural antibody and complement-mediated antigen processing and presentation by B lymphocytes. J. Immunol. 152: 1727-1737.
61. Kozono, Y., R. Abe, H. Kozono, R. G. Kelly, T. Azuma, and V. M. Holers. 1998. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells. J. Immunol. 160: 1565-1572.